CO6630153A2 - Predicción y optimización para terapia sangúínea en falla renal especialmente hemodialisis domiciliaria - Google Patents

Predicción y optimización para terapia sangúínea en falla renal especialmente hemodialisis domiciliaria

Info

Publication number
CO6630153A2
CO6630153A2 CO12207312A CO12207312A CO6630153A2 CO 6630153 A2 CO6630153 A2 CO 6630153A2 CO 12207312 A CO12207312 A CO 12207312A CO 12207312 A CO12207312 A CO 12207312A CO 6630153 A2 CO6630153 A2 CO 6630153A2
Authority
CO
Colombia
Prior art keywords
patient
phosphorus
hemodialysis
treatment session
during
Prior art date
Application number
CO12207312A
Other languages
English (en)
Inventor
Alp Akonur
Jhon Kenneth Leypoldt
Ying Cheng Lo
Baris Ugur Agar
Original Assignee
Baxter Int
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Baxter Int filed Critical Baxter Int
Publication of CO6630153A2 publication Critical patent/CO6630153A2/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
    • A61M1/14—Dialysis systems; Artificial kidneys; Blood oxygenators ; Reciprocating systems for treatment of body fluids, e.g. single needle systems for hemofiltration or pheresis
    • A61M1/16—Dialysis systems; Artificial kidneys; Blood oxygenators ; Reciprocating systems for treatment of body fluids, e.g. single needle systems for hemofiltration or pheresis with membranes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
    • A61M1/14—Dialysis systems; Artificial kidneys; Blood oxygenators ; Reciprocating systems for treatment of body fluids, e.g. single needle systems for hemofiltration or pheresis
    • A61M1/16—Dialysis systems; Artificial kidneys; Blood oxygenators ; Reciprocating systems for treatment of body fluids, e.g. single needle systems for hemofiltration or pheresis with membranes
    • A61M1/1601—Control or regulation
    • A61M1/1613—Profiling or modelling of patient or predicted treatment evolution or outcome
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
    • A61M1/14—Dialysis systems; Artificial kidneys; Blood oxygenators ; Reciprocating systems for treatment of body fluids, e.g. single needle systems for hemofiltration or pheresis
    • A61M1/16—Dialysis systems; Artificial kidneys; Blood oxygenators ; Reciprocating systems for treatment of body fluids, e.g. single needle systems for hemofiltration or pheresis with membranes
    • A61M1/1601—Control or regulation
    • A61M1/1619—Sampled collection of used dialysate, i.e. obviating the need for recovery of whole dialysate quantity for post-dialysis analysis
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H20/00—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance
    • G16H20/40—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance relating to mechanical, radiation or invasive therapies, e.g. surgery, laser therapy, dialysis or acupuncture
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2202/00—Special media to be introduced, removed or treated
    • A61M2202/04—Liquids
    • A61M2202/0496—Urine
    • A61M2202/0498—Urea
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2205/00—General characteristics of the apparatus
    • A61M2205/15—Detection of leaks
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2205/00—General characteristics of the apparatus
    • A61M2205/50—General characteristics of the apparatus with microprocessors or computers
    • A61M2205/502—User interfaces, e.g. screens or keyboards
    • A61M2205/505—Touch-screens; Virtual keyboard or keypads; Virtual buttons; Soft keys; Mouse touches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2205/00—General characteristics of the apparatus
    • A61M2205/50—General characteristics of the apparatus with microprocessors or computers
    • A61M2205/52—General characteristics of the apparatus with microprocessors or computers with memories providing a history of measured variating parameters of apparatus or patient

Abstract

Un método para predecir concentraciones de fósforo en suero en un paciente durante hemodiálisis incluye medir las concentraciones de fósforo en suero del paciente durante un tiempo de sesión de tratamiento de hemodiálisis y un índice de ultrafiltración calculado por una diferencia entre el peso corporal pre y pos dialítico del paciente durante una sesión de tratamiento de hemodiálisis inicial dividido por un tiempo de tratamiento total de la sesión de tratamiento y estimar una depuración de movilización de fósforo y un volumen de distribución pre-diálisis de fósforo para el paciente. Luego se pueden predecir las concentraciones de fósforo en suero del paciente en cualquier momento durante cualquier sesión de tratamiento de hemodiálisis con la depuración estimada de movilización de fósforo y volumen de distribución pre-diálisis de fósforo del paciente.
CO12207312A 2010-04-16 2012-11-15 Predicción y optimización para terapia sangúínea en falla renal especialmente hemodialisis domiciliaria CO6630153A2 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US32511310P 2010-04-16 2010-04-16

Publications (1)

Publication Number Publication Date
CO6630153A2 true CO6630153A2 (es) 2013-03-01

Family

ID=44041518

Family Applications (3)

Application Number Title Priority Date Filing Date
CO12205072A CO6660434A2 (es) 2010-04-16 2012-11-14 Ensamble de lámpara elevada en estado sólido para uso exterior
CO12207315A CO6620023A2 (es) 2010-04-16 2012-11-15 Predicción y optimización para terapia sanguínea en falla renal, especialmente hemodiálisis domiciliaria
CO12207312A CO6630153A2 (es) 2010-04-16 2012-11-15 Predicción y optimización para terapia sangúínea en falla renal especialmente hemodialisis domiciliaria

Family Applications Before (2)

Application Number Title Priority Date Filing Date
CO12205072A CO6660434A2 (es) 2010-04-16 2012-11-14 Ensamble de lámpara elevada en estado sólido para uso exterior
CO12207315A CO6620023A2 (es) 2010-04-16 2012-11-15 Predicción y optimización para terapia sanguínea en falla renal, especialmente hemodiálisis domiciliaria

Country Status (10)

Country Link
EP (3) EP2558966B1 (es)
JP (8) JP5747072B2 (es)
AU (2) AU2011239488B2 (es)
BR (1) BR112012026361A2 (es)
CA (2) CA2796505C (es)
CO (3) CO6660434A2 (es)
ES (2) ES2802609T3 (es)
MX (4) MX2012012062A (es)
NZ (2) NZ602996A (es)
WO (2) WO2011130669A1 (es)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9132219B2 (en) 2010-04-16 2015-09-15 Baxter International Inc. Therapy prediction and optimization of serum potassium for renal failure blood therapy, especially home hemodialysis
US8868350B2 (en) 2010-04-16 2014-10-21 Baxter International Inc. Therapy prediction and optimization for renal failure blood therapy, especially home hemodialysis
MX361881B (es) * 2013-08-16 2018-12-18 Baxter Int Prediccion y optimizacion de terapia de potasio en suero para terapia de sangre para insuficiencia renal, especialmente hemodialisis domiciliaria.
DE102014005122A1 (de) * 2014-04-08 2015-10-08 Fresenius Medical Care Deutschland Gmbh Verfahren zur Abschätzung der Behandlungsdauer einer Pertionealdialyse-Behandlung
US10525182B2 (en) 2014-10-10 2020-01-07 Nxstage Medical, Inc. Flow balancing devices, methods, and systems
JP7086926B2 (ja) 2016-07-18 2022-06-20 ネクステージ メディカル インコーポレイテッド フローバランシングの装置、方法、及びシステム
US11865243B2 (en) 2016-08-30 2024-01-09 Nxstage Medical, Inc. Parameter monitoring in medical treatment systems
JP2019212249A (ja) * 2018-06-10 2019-12-12 大 益満 プログラム及び情報処理システム
CN115050238B (zh) * 2022-07-08 2024-03-12 卡斯柯信号有限公司 一种基于真实ctc系统的多模式切换仿真实训系统

Family Cites Families (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5602116A (en) * 1988-08-02 1997-02-11 Bone Care International, Inc. Method for treating and preventing secondary hyperparathyroidism
US5230702A (en) * 1991-01-16 1993-07-27 Paradigm Biotechnologies Partnership Hemodialysis method
ES2132260T3 (es) * 1992-10-13 1999-08-16 Baxter Int Modulo de muestreo de fluido.
JP2812460B2 (ja) * 1995-10-04 1998-10-22 日機装株式会社 血液浄化モニタ装置
JP3402360B2 (ja) * 1998-08-21 2003-05-06 株式会社ジェイ・エム・エス 腹膜透析システム
AUPP790898A0 (en) * 1998-12-23 1999-01-28 Life Therapeutics Limited Renal dialysis
DE60204883T3 (de) * 2002-09-05 2013-10-24 Gambro Lundia Ab Steuerung für eine Blutbehandlungsvorrichtung
US20040048837A1 (en) * 2002-09-06 2004-03-11 Lazarus J. Michael Method for treatment of renal disease
JP4379027B2 (ja) * 2003-05-14 2009-12-09 株式会社ジェイ・エム・エス 腹膜透析および血液透析併用プランニング方法ならびに腹膜透析および血液透析併用プランニング装置
DE602005020697D1 (de) * 2005-06-09 2010-05-27 Gambro Lundia Ab Medizinische vorrichtung und verfahren zum einrichten einer medizinischen vorrichtung
DE102006045437A1 (de) * 2006-09-26 2008-04-03 Fresenius Medical Care Deutschland Gmbh Vorrichtung und Verfahren zur Vorgabe einer Dialysierflüssigkeitsrate oder Blutflussrate für eine extrakorporale Blutbehandlung
US9028691B2 (en) 2007-02-27 2015-05-12 Deka Products Limited Partnership Blood circuit assembly for a hemodialysis system
US20080253911A1 (en) 2007-02-27 2008-10-16 Deka Products Limited Partnership Pumping Cassette
US8042563B2 (en) 2007-02-27 2011-10-25 Deka Products Limited Partnership Cassette system integrated apparatus
US20090107335A1 (en) 2007-02-27 2009-04-30 Deka Products Limited Partnership Air trap for a medical infusion device
US8409441B2 (en) * 2007-02-27 2013-04-02 Deka Products Limited Partnership Blood treatment systems and methods
US8562834B2 (en) 2007-02-27 2013-10-22 Deka Products Limited Partnership Modular assembly for a portable hemodialysis system
US8393690B2 (en) 2007-02-27 2013-03-12 Deka Products Limited Partnership Enclosure for a portable hemodialysis system
EP2174292A1 (en) * 2007-08-03 2010-04-14 Koninklijke Philips Electronics N.V. A method, apparatus, computer-readable medium and use for pharmacokinetic modeling
US9514283B2 (en) 2008-07-09 2016-12-06 Baxter International Inc. Dialysis system having inventory management including online dextrose mixing
US8168063B2 (en) 2008-07-09 2012-05-01 Baxter International Inc. Dialysis system having filtering method for determining therapy prescriptions
US8057679B2 (en) 2008-07-09 2011-11-15 Baxter International Inc. Dialysis system having trending and alert generation
US8062513B2 (en) * 2008-07-09 2011-11-22 Baxter International Inc. Dialysis system and machine having therapy prescription recall
US7981281B2 (en) 2008-07-09 2011-07-19 Baxter International, Inc. Dialysis system having regimen generation methodology
EP2163272B1 (en) * 2008-09-15 2014-06-25 B. Braun Avitum AG Device to early predict the Kt/V parameter in kidney substitution treatments
US8999169B2 (en) * 2008-10-17 2015-04-07 Fresenius Medical Care Holdings, Inc. Method of determining a phosphorus binder dosage for a dialysis patient

Also Published As

Publication number Publication date
EP2558967B1 (en) 2020-04-15
AU2011239488A1 (en) 2012-11-08
JP6043850B2 (ja) 2016-12-14
JP6018567B2 (ja) 2016-11-02
MX2022001536A (es) 2022-05-26
CO6620023A2 (es) 2013-02-15
JP2017094150A (ja) 2017-06-01
WO2011130668A1 (en) 2011-10-20
MX2012012062A (es) 2013-06-28
EP2558966B1 (en) 2014-07-16
JP2019188179A (ja) 2019-10-31
JP2024045513A (ja) 2024-04-02
NZ602996A (en) 2015-02-27
AU2011239488B2 (en) 2015-05-21
AU2011239489A1 (en) 2012-11-08
ES2802609T3 (es) 2021-01-20
MX2012012061A (es) 2013-06-28
JP6543279B2 (ja) 2019-07-10
JP7438257B2 (ja) 2024-02-26
JP5747072B2 (ja) 2015-07-08
EP2558967A1 (en) 2013-02-20
AU2011239489B2 (en) 2015-04-02
CA2796496A1 (en) 2011-10-20
CA2796505C (en) 2018-12-11
CA2796505A1 (en) 2011-10-20
JP7057321B2 (ja) 2022-04-19
MX347513B (es) 2017-04-28
JP2015165914A (ja) 2015-09-24
BR112012026361A2 (pt) 2019-09-24
EP3706134A1 (en) 2020-09-09
CO6660434A2 (es) 2013-04-30
EP2558966A1 (en) 2013-02-20
JP2015221383A (ja) 2015-12-10
JP2013524893A (ja) 2013-06-20
ES2501715T3 (es) 2014-10-02
WO2011130669A1 (en) 2011-10-20
JP6078582B2 (ja) 2017-02-08
CA2796496C (en) 2018-03-20
JP2013524892A (ja) 2013-06-20
JP2022095842A (ja) 2022-06-28
NZ603010A (en) 2014-05-30

Similar Documents

Publication Publication Date Title
CO6630153A2 (es) Predicción y optimización para terapia sangúínea en falla renal especialmente hemodialisis domiciliaria
MX2016002083A (es) Prediccion y optimizacion de terapia de potasio en suero para terapia de sangre para insuficiencia renal, especialmente hemodialisis domiciliaria.
BR112013026319A2 (pt) método e aparelho para o monitoramento de um tratamento de um paciente, preferivelmente para o monitoramento da hemodiálise, hemodiafiltração e/ou diálise peritoneal
MX362597B (es) Sistema y metodo para intercambio de dialisis peritoneal teniendo una unidad energizante reutilizable.
WO2013101292A3 (en) Fluid volume monitoring for patients with renal disease
GR20110100184A (el) Συστημα ανταλλαγης υγρων για ιατρικη χρηση
EA201590062A1 (ru) Применение лимонно-кислого железа при лечении пациентов с хронической почечной недостаточностью
MX370297B (es) Procedimientos de diálisis de anticoagulación regional con citrato.
SG10201600502XA (en) Methods and kits for predicting the risk of respiratory failure, renal failure or thrombopenia in a septic patient by measuring endocan levels in blood
TR201820019T4 (tr) Metilglioksal hidroimidazolonun (MGH1) belirlenmesi aracılığıyla diyabet yönetiminin geliştirilmesine yönelik yöntem ve kit.
CL2013001382A1 (es) Metodo para aumentar la seguridad y la eficacia de las transfusiones de sangre, que comprende administrar a un paciente una composicion farmaceutica que comprende un copolimero de polioxietileno/polioxipropileno, en donde la composicion se mezcla con la sangre antes de la transfusion, o se administra al paciente antes o despues de la transfusion.
BR112013028911A2 (pt) dispositivo médico removível implantável em vasos sanguíneos, particularmente na aorta toracica com aneurisma
Karimdzhanov et al. Chronic kidney disease in children: problems of arterial hypertension
RU2013155841A (ru) Способ ранней диагностики хронической болезни почек
RU2012137712A (ru) Способ прогнозирования вероятности благоприятного или летального исхода у больных с инфекционно-воспалительными заболеваниями органов мочевой системы
UA64465U (ru) Способ диагностики дисплазии соединительной ткани у больных с туберкулезом органов дыхания
Samalin Sedation: case report
UA62757U (ru) Способ прогнозирования адекватности программного гемодиализа у больных с хронической болезнью почек v стадии
UA74473U (ru) Способ прогнозирования анемии у больных с хронической сердечной недостаточностью, сопровождающейся хронической болезнью почек
Lippi et al. PLASMA LEVELS OF HOMOCYSTEINE IN NEPHROPATIC DOGS SUBMITTED TO INTERMITTENT HAEMODIALYSIS
Porcelli Clozapine/haloperidol
UA62777U (ru) Способ ранней диагностики степени тяжести острой почечной недостаточности разного генеза
王丽雅 Application of KDQOL-SF^(TM) 1.3 version in evaluating quality of life of maintenance hemodialysis patients in multiple centers
Chelazzi et al. Effect of continuous high cutoff hemodialysis on vascular permeability of septic patients with acute kidney injury
Gohari Heparin-induced thrombocytopenia: case report